Literature DB >> 16455069

Characterisation of cryoinjury in Euglena gracilis using flow-cytometry and cryomicroscopy.

Roland A Fleck1, Roger W Pickup, John G Day, Erica E Benson.   

Abstract

Flow-cytometry and cryomicroscopy elucidated that the unicellular algal protist Euglena gracilis was undamaged by cryoprotectant added at 0 degree C, and super-cooling in the absence of ice. Cryoinjuries were however induced by: osmotic shock resulting from excessive cryodehydration, intracellular ice, and fracturing of the frozen medium on thawing. Suboptimal cooling at -0.3 degrees C min(-1) to -60 degrees C and osmotic shock invariably resulted in damage to the organism's pellicle and osmoregulatory system causing, a significant (P > 0.005) increase in cell size. Cell damage was not repairable and led to death. The responses of E. gracilis to cryopreservation as visualised by flow-cytometry and cryomicroscopy assisted the development of an improved storage protocol. This comprised: cryoprotection with methanol [10%(v/v)] at 0 degree C, cooling at 0.5 degrees C min(-1) to -60 degrees C, isothermal hold for 30 min, and direct immersion in liquid nitrogen. Highest post-thaw viability (>60%) was obtained using two-step thawing, which involved initial slow warming to -130 degrees C followed by relatively rapid warming (approximately 90 degrees C min(-1)) to ambient temperature (ca. 25 degrees C).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455069     DOI: 10.1016/j.cryobiol.2005.12.003

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  2 in total

1.  A simple and effective cryopreservation protocol for the industrially important and model organism, Euglena gracilis.

Authors:  Mahfuzur R Shah; Erin N Morrison; Adam J Noble; Scott C Farrow
Journal:  STAR Protoc       Date:  2021-12-15

2.  Impact of procedural steps and cryopreservation agents in the cryopreservation of chlorophyte microalgae.

Authors:  Tony V L Bui; Ian L Ross; Gisela Jakob; Ben Hankamer
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.